stilPCR increases the effective sequencing length of Illumina targeted next-generation sequencing

被引:0
|
作者
Limberis, Jason D. [1 ]
Nagel, Roland J. [2 ]
Chakravorty, Soumitesh [2 ]
Block, Dena [2 ]
Dewell, Scott [2 ]
Nalyvayko, Alina [1 ]
Howard, Zach [3 ]
Theron, Grant [4 ]
Venter, Rouxjeane [4 ]
Metcalfe, John Z. [1 ]
机构
[1] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp & Trauma Ctr, Div Pulm & Crit Care Med, San Francisco, CA 94115 USA
[2] Cepheid Inc, Sunnyvale, CA USA
[3] Univ Calif San Francisco, Div Expt Med, San Francisco, CA USA
[4] Stellenbosch Univ, DSI NRF Ctr Excellence Biomed TB Res, South African Med Res Council Ctr TB Res, Div Mol Biol & Human Genet,Fac Med & Hlth Sci, Stellenbosch, South Africa
来源
PLOS ONE | 2024年 / 19卷 / 12期
关键词
D O I
10.1371/journal.pone.0314265
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Identifying pathogens, resistance-conferring mutations, and strain types through targeted amplicon sequencing is an important tool. However, due to the limitations of short read sequencing, many applications require the division of limited clinical samples. Here, we present stilPCR (single-tube Illumina long read PCR), which allows the generation of hemi-nested amplicons in a single tube, with Illumina indexes and adapters, effectively increasing the Illumina read length without increasing the input requirements of reagents or sample. We have successfully utilized stilPCR on clinical sputum from tuberculosis patients to detect drug resistance mutations.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Reproducibility of Clinical Samples by the Illumina TruSight Myeloid Next-generation Sequencing Panel
    Commander, L.
    Booker, J. K.
    Thorne, L. B.
    Gulley, M. L.
    Montgomery, N. D.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2018, 20 (06): : 918 - 918
  • [32] Next-Generation Sequencing Demands Next-Generation Phenotyping
    Hennekam, Raoul C. M.
    Biesecker, Leslie G.
    HUMAN MUTATION, 2012, 33 (05) : 884 - 886
  • [33] Targeted Sequencing of Clinically Significant Gene Mutations in Leukemia Using Next-Generation Sequencing
    Liu, L.
    Chang, F.
    Fang, E.
    Zhang, G.
    Li, M. M.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2014, 16 (06): : 726 - 727
  • [34] Measuring the diversity of the human microbiota with targeted next-generation sequencing
    Finotello, Francesca
    Mastrorilli, Eleonora
    Di Camillo, Barbara
    BRIEFINGS IN BIOINFORMATICS, 2018, 19 (04) : 679 - 692
  • [35] MPD: multiplex primer design for next-generation targeted sequencing
    Wingo, Thomas S.
    Kotlar, Alex
    Cutler, David J.
    BMC BIOINFORMATICS, 2017, 18
  • [36] Targeted next-generation sequencing in Brazilian individuals with Osteogenesis Imperfecta
    dos Santos, P. A. C.
    Carneiro, I. P. M.
    Chiabai, M. A.
    Pogue, R. E.
    Yamagutti, P. M.
    Castro, L. C.
    Mazzeu, J. F.
    Oliveira, S. F.
    Acevedo-Poppe, A. C.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2018, 26 : 244 - 245
  • [37] Targeted next-generation sequencing as a diagnostic tool in neuromuscular disorders
    Lehtinen, S.
    Penttila, S.
    Suominen, T.
    Evila, A.
    Arumilli, M.
    Hackman, P.
    Udd, B.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S162 - S162
  • [38] Targeted Next-Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes
    Han, S. M.
    Park, J.
    Lee, J. H.
    Lee, S. S.
    Kim, H.
    Han, H.
    Kim, Y.
    Yi, S.
    Cho, J-Y
    Jang, I-J
    Lee, M. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (03) : 396 - 405
  • [39] Targeted next-generation sequencing - Identification of Lynch syndrome cases
    Talseth-Palmer, B. A.
    Evans, T. J.
    Spigelman, A.
    Scott, R. J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S103 - S103
  • [40] Clinical validation of targeted next-generation sequencing for glioblastoma patients
    Trepant, Anne-Laure
    Le Mercier, Marie
    Maris, Calliope
    De Neve, Nancy
    Blanchard, Oriane
    D'Haene, Nicky
    Salmon, Isabelle
    CANCER RESEARCH, 2015, 75